Cargando…

The Efficacy of Low Molecular Weight Heparin for the Prevention of Venous Thromboembolism after Hip Fracture Surgery in Korean Patients

PURPOSE: The aim of this study was to investigate the efficacy of low-molecular-weight heparin (LMWH) for the prevention of venous thromboembolism in Korean patients who underwent hip fracture surgery (HFS). MATERIALS AND METHODS: Prospectively, a total 181 cases were classified into the LMWH user g...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Kwang-Kyoun, Won, Yougun, Won, Ye-Yeon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Yonsei University College of Medicine 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4960388/
https://www.ncbi.nlm.nih.gov/pubmed/27401653
http://dx.doi.org/10.3349/ymj.2016.57.5.1209
_version_ 1782444520816771072
author Kim, Kwang-Kyoun
Won, Yougun
Won, Ye-Yeon
author_facet Kim, Kwang-Kyoun
Won, Yougun
Won, Ye-Yeon
author_sort Kim, Kwang-Kyoun
collection PubMed
description PURPOSE: The aim of this study was to investigate the efficacy of low-molecular-weight heparin (LMWH) for the prevention of venous thromboembolism in Korean patients who underwent hip fracture surgery (HFS). MATERIALS AND METHODS: Prospectively, a total 181 cases were classified into the LMWH user group (116 cases) and LMWH non-user group (65 cases). Each group was sub-classified according to fracture types as follows: 81 cases of intertrochanteric fracture (group A: 49, group B: 32) and 100 cases of neck fracture (group C: 67, group D: 33). We compared the incidence of deep vein thrombosis (DVT) and pulmonary embolism (PE) according to LMWH use. RESULTS: Of the 181 cases, four DVTs were found in the LMWH user groups (1 in group A, and 3 in group C). One case of PE was found in LMWH non-user group D. The incidences of DVT and PE showed no statistically significant differences between the LMWH user and non-user groups (p=0.298 and 0.359, respectively). In subgroup analysis, no statistically significant differences were found between groups A and B and between groups C and D. CONCLUSION: The administration of LMWH was not effective in the prevention of venous thromboembolism and PE in the Korean patients who underwent HFS.
format Online
Article
Text
id pubmed-4960388
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Yonsei University College of Medicine
record_format MEDLINE/PubMed
spelling pubmed-49603882016-09-01 The Efficacy of Low Molecular Weight Heparin for the Prevention of Venous Thromboembolism after Hip Fracture Surgery in Korean Patients Kim, Kwang-Kyoun Won, Yougun Won, Ye-Yeon Yonsei Med J Original Article PURPOSE: The aim of this study was to investigate the efficacy of low-molecular-weight heparin (LMWH) for the prevention of venous thromboembolism in Korean patients who underwent hip fracture surgery (HFS). MATERIALS AND METHODS: Prospectively, a total 181 cases were classified into the LMWH user group (116 cases) and LMWH non-user group (65 cases). Each group was sub-classified according to fracture types as follows: 81 cases of intertrochanteric fracture (group A: 49, group B: 32) and 100 cases of neck fracture (group C: 67, group D: 33). We compared the incidence of deep vein thrombosis (DVT) and pulmonary embolism (PE) according to LMWH use. RESULTS: Of the 181 cases, four DVTs were found in the LMWH user groups (1 in group A, and 3 in group C). One case of PE was found in LMWH non-user group D. The incidences of DVT and PE showed no statistically significant differences between the LMWH user and non-user groups (p=0.298 and 0.359, respectively). In subgroup analysis, no statistically significant differences were found between groups A and B and between groups C and D. CONCLUSION: The administration of LMWH was not effective in the prevention of venous thromboembolism and PE in the Korean patients who underwent HFS. Yonsei University College of Medicine 2016-09-01 2016-06-30 /pmc/articles/PMC4960388/ /pubmed/27401653 http://dx.doi.org/10.3349/ymj.2016.57.5.1209 Text en © Copyright: Yonsei University College of Medicine 2016 http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Kim, Kwang-Kyoun
Won, Yougun
Won, Ye-Yeon
The Efficacy of Low Molecular Weight Heparin for the Prevention of Venous Thromboembolism after Hip Fracture Surgery in Korean Patients
title The Efficacy of Low Molecular Weight Heparin for the Prevention of Venous Thromboembolism after Hip Fracture Surgery in Korean Patients
title_full The Efficacy of Low Molecular Weight Heparin for the Prevention of Venous Thromboembolism after Hip Fracture Surgery in Korean Patients
title_fullStr The Efficacy of Low Molecular Weight Heparin for the Prevention of Venous Thromboembolism after Hip Fracture Surgery in Korean Patients
title_full_unstemmed The Efficacy of Low Molecular Weight Heparin for the Prevention of Venous Thromboembolism after Hip Fracture Surgery in Korean Patients
title_short The Efficacy of Low Molecular Weight Heparin for the Prevention of Venous Thromboembolism after Hip Fracture Surgery in Korean Patients
title_sort efficacy of low molecular weight heparin for the prevention of venous thromboembolism after hip fracture surgery in korean patients
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4960388/
https://www.ncbi.nlm.nih.gov/pubmed/27401653
http://dx.doi.org/10.3349/ymj.2016.57.5.1209
work_keys_str_mv AT kimkwangkyoun theefficacyoflowmolecularweightheparinforthepreventionofvenousthromboembolismafterhipfracturesurgeryinkoreanpatients
AT wonyougun theefficacyoflowmolecularweightheparinforthepreventionofvenousthromboembolismafterhipfracturesurgeryinkoreanpatients
AT wonyeyeon theefficacyoflowmolecularweightheparinforthepreventionofvenousthromboembolismafterhipfracturesurgeryinkoreanpatients
AT kimkwangkyoun efficacyoflowmolecularweightheparinforthepreventionofvenousthromboembolismafterhipfracturesurgeryinkoreanpatients
AT wonyougun efficacyoflowmolecularweightheparinforthepreventionofvenousthromboembolismafterhipfracturesurgeryinkoreanpatients
AT wonyeyeon efficacyoflowmolecularweightheparinforthepreventionofvenousthromboembolismafterhipfracturesurgeryinkoreanpatients